128
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The Footprint of Diabetes Mellitus on the Characteristics and Response to Anti-Tuberculous Therapy in Patients with Pulmonary Tuberculosis from Saudi Arabia

&
Pages 5303-5312 | Published online: 10 Dec 2021

References

  • Silva DR, Mello FCQ, Migliori GB. Tuberculosis series 2020. J Bras Pneumol. 2020;46(2):e20200027. doi:10.36416/1806-3756/e2020002732130340
  • Tellier R, Li Y, Cowling BJ, Tang JW. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis. 2019;19(1):101. doi:10.1186/s12879-019-3707-y30704406
  • Koegelenberg CFN, Schoch OD, Lange C. Tuberculosis: the past, the present and the future. Respiration. 2021;100(7):553–556. doi:10.1159/00051650934034257
  • Di Gennaro F, Gualano G, Timelli L, et al. Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: data from an Italian Infectious Disease Referral Hospital. Antibiotics. 2021;10(3):272. doi:10.3390/antibiotics1003027233800406
  • Almutairi FM, Tayeb T, Alhakeem R, Saeed AB, Assiri A, McNabb SJN. Distribution and determinants of tuberculosis in the Kingdom of Saudi Arabia from 2005 to 2012. J Epidemiol Glob Health. 2018;Suppl(Suppl 1):S23–S28. doi:10.1016/j.jegh.2017.08.002
  • Al-Sahafi A, Al-Sayali MM, Mandoura N, et al. Treatment outcomes among tuberculosis patients in Jeddah, Saudi Arabia: results of a community mobile outreach directly observed Treatment, Short-course (DOTS) project, compared to a standard facility-based DOTS: a randomized controlled trial. J Clin Tuberc Other Mycobact Dis. 2020;22:100210. doi:10.1016/j.jctube.2020.10021033490640
  • Peer N, Balakrishna Y, Durao S. Screening for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020;5(5):CD005266. doi:10.1002/14651858.CD00526632470201
  • Wu Y, Fu R, Lei C, et al. Estimates of Type 2 Diabetes Mellitus Burden Attributable to Particulate Matter Pollution and Its 30-Year Change Patterns: a Systematic Analysis of Data From the Global Burden of Disease Study 2019. Front Endocrinol. 2021;12:689079. doi:10.3389/fendo.2021.689079
  • van Crevel R, Critchley JA. The interaction of diabetes and tuberculosis: translating research to policy and practice. Trop Med Infect Dis. 2021;6(1):8. doi:10.3390/tropicalmed601000833435609
  • Chen Z, Liu Q, Song R, et al. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocr Disord. 2021;21(1):123. doi:10.1186/s12902-021-00779-634134685
  • Solá E, Rivera C, Mangual M, Martinez J, Rivera K, Fernandez R. Diabetes mellitus: an important risk factor for reactivation of tuberculosis. Endocrinol Diabetes Metab Case Rep. 2016;2016:16–0035. doi:10.1530/EDM-16-0035
  • Ayelign B, Negash M, Genetu M, Wondmagegn T, Shibabaw T. Immunological impacts of diabetes on the susceptibility of Mycobacterium tuberculosis. J Immunol Res. 2019;2019:6196532. doi:10.1155/2019/619653231583258
  • International Union Against Tuberculosis and Lung Disease (IUATLD). Technical Guide. Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries. 5th ed. 2000.
  • World Health Organization. Treatment of Tuberculosis: Guidelines. 4th ed. Geneva, Switzerland: World Health Organization; 2010.
  • American Diabetes Association. Standards of medical care in diabetes-2019 abridged for primary care providers. Clin Diabetes. 2019;37(1):11–34. doi:10.2337/cd18-010530705493
  • Hewage S, Somasundaram N, Ratnasamy V, et al. Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka. PLoS One. 2021;16(4):e0249787. doi:10.1371/journal.pone.024978733831095
  • Binkhamis KM, Bahatheg MA, Altahan FA, et al. Prevalence and outcome of isoniazid-monoresistant tuberculosis at a university hospital in Saudi Arabia. Saudi Med J. 2021;42(6):636–642. doi:10.15537/smj.2021.42.6.2020083234078725
  • Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health. 2019;7(4):e448–e460. doi:10.1016/S2214-109X(18)30487-X30819531
  • Pande T, Huddart S, Xavier W, et al. Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: a descriptive analysis. PLoS One. 2018;13(7):e0200838. doi:10.1371/journal.pone.020083830021016
  • Dabhi PA, Thangakunam B, Gupta R, et al. Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital. PLoS One. 2020;15(6):e0233385. doi:10.1371/journal.pone.023338532502176
  • Gautam S, Shrestha N, Mahato S, Nguyen TPA, Mishra SR, Berg-Beckhoff G. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis. Sci Rep. 2021;11(1):2113. doi:10.1038/s41598-021-81057-233483542
  • Sousa GGDS, Pascoal LM, Costa ACPJ, et al. Trend and factors associated with tuberculosis-diabetes mellitus comorbidity in a northeastern Brazilian municipality. Rev Bras Enferm. 2021;74(3):e20201238. doi:10.1590/0034-7167-2020-123834259732
  • Pizzol D, Di Gennaro F, Chhaganlal KD, et al. Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique. Afr Health Sci. 2017;17(3):773–779. doi:10.4314/ahs.v17i3.2029085405
  • Di Gennaro F, Marotta C, Antunes M, Pizzol D. Diabetes in active tuberculosis in low-income countries: to test or to take care? Lancet Glob Health. 2019;7(6):e707. doi:10.1016/S2214-109X(19)30173-131097272
  • Cordeiro da Costa J, Oliveira O, Baía L, Gaio R, Correia-Neves M, Duarte R. Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort. Eur Respir J. 2016;48(1):264–268. doi:10.1183/13993003.00254-201627174884
  • Alavi SM, Khoshkho MM, Salmanzadeh S, Eghtesad M. Comparison of epidemiological, clinical, laboratory and radiological features of hospitalized diabetic and non-diabetic patients with pulmonary tuberculosis at razi hospital in ahvaz. Jundishapur J Microbiol. 2014;7(9):e12447. doi:10.5812/jjm.1244725485064
  • Tahir Z, Ahmad MU, Akhtar AM, Yaqub T, Mushtaq MH, Javed H. Diabetes mellitus among tuberculosis patients: a cross sectional study from Pakistan. Afr Health Sci. 2016;16(3):671–676. doi:10.4314/ahs.v16i3.527917198
  • Wessels J, Walsh CM, Nel M. Smoking habits and alcohol use of patients with tuberculosis at Standerton Tuberculosis Specialised Hospital, Mpumalanga, South Africa. Health SA. 2019;24:1146. doi:10.4102/hsag.v24i0.114631934425
  • Gil-Santana L, Almeida-Junior JL, Oliveira CA, et al. Diabetes is associated with worse clinical presentation in tuberculosis patients from Brazil: a Retrospective Cohort Study. PLoS One. 2016;11(1):e0146876. doi:10.1371/journal.pone.014687626752596
  • Leung CC, Yew WW, Mok TYW, et al. Effects of diabetes mellitus on the clinical presentation and treatment response in tuberculosis. Respirology. 2017;22(6):1225–1232. doi:10.1111/resp.1301728244689
  • Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13–24. doi:10.1111/imm.1276228543817
  • Alkabab YM, Enani MA, Indarkiri NY, Heysell SK. Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia. Infect Drug Resist. 2018;11:37–43. doi:10.2147/IDR.S15184429379307
  • Paul KK, Alkabab YMA, Rahman MM, et al. A public-private model to scale up diabetes mellitus screening among people accessing tuberculosis diagnostics in Dhaka, Bangladesh. Int J Infect Dis. 2020;92:56–61. doi:10.1016/j.ijid.2020.01.00131926354
  • Huang LK, Jiang LD, Lai YC, Wu MH, Chang SC. Pulmonary tuberculous cavities in diabetic patients: glycemic control is still the dominant factor despite the emerging role of metformin. J Chin Med Assoc. 2019;82(8):628–634. doi:10.1097/JCMA31305342
  • Asemahagn MA. Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: a longitudinal study. BMC Pulm Med. 2021;21(1):118. doi:10.1186/s12890-021-01483-w33832466
  • Shariff NM, Safian N. Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: a case control study. Int J Mycobacteriol. 2015;4(4):323–329. doi:10.1016/j.ijmyco.2015.09.00326964816
  • Viswanathan AA, Gawde NC. Effect of type II diabetes mellitus on treatment outcomes of tuberculosis. Lung India. 2014;31(3):244–248. doi:10.4103/0970-2113.13576425125811
  • Singla R, Bharty SK, Gupta UA, et al. Sputum smear positivity at two months in previously untreated pulmonary tuberculosis patients. Int J Mycobacteriol. 2013;2(4):199–205. doi:10.1016/j.ijmyco.2013.08.00226786122
  • Salindri AD, Kipiani M, Kempker RR, et al. Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis. Open Forum Infect Dis. 2016;3(3):ofw126. doi:10.1093/ofid/ofw12627419188
  • Dousa KM, Hamad A, Albirair M, et al. Impact of diabetes mellitus on the presentation and response to treatment of adults with pulmonary tuberculosis in qatar. Open Forum Infect Dis. 2018;6(1):ofy335. doi:10.1093/ofid/ofy33530631793
  • Mave V, Gaikwad S, Barthwal M, et al. Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India. Open Forum Infect Dis. 2021;8(4):ofab097. doi:10.1093/ofid/ofab09733884278
  • Lyu M, Wang D, Zhao J, et al. A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus. Int J Infect Dis. 2020;97:69–77. doi:10.1016/j.ijid.2020.05.08032474202
  • Ghimire S, Karki S, Maharjan B, et al. Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study. BMJ Open Respir Res. 2020;7(1):e000606. doi:10.1136/bmjresp-2020-000606
  • Di Gennaro F, Vittozzi P, Gualano G, et al. Active Pulmonary Tuberculosis in Elderly Patients: a 2016–2019 Retrospective Analysis from an Italian Referral Hospital. Antibiotics. 2020;9(8):489. doi:10.3390/antibiotics9080489
  • Di Gennaro F, Pisani L, Veronese N, et al. Potential diagnostic properties of chest ultrasound in thoracic tuberculosis-a systematic review. Int J Environ Res Public Health. 2018;15(10):2235. doi:10.3390/ijerph15102235
  • Elhassan MM, Hemeg HA, Elmekki MA, Turkistani KA, Abdul-Aziz AA. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Munawarah, Saudi Arabia. Infect Disord Drug Targets. 2017;17(1):14–23. doi:10.2174/187152651766616111610424227848902
  • Ahmed-Abakur EH, Saad Alnour TM. Detection of multidrug resistant Mycobacterium tuberculosis in Tabuk, Saudi Arabia, using Genotype MTBDRplus. Int J Mycobacteriol. 2019;8(1):25–28. doi:10.4103/ijmy.ijmy_29_1930860175